SFB128 Project B01: Immune regulation at the CNS barriers and in the CNS: role of immune cell trafficking

Basic data for this project

Type of projectSubproject in DFG-joint project hosted at University of Münster
Duration at the University of Münster01/07/2016 - 31/12/2020 | 2nd Funding period

Description

Blocking of adhesion molecules can reduce MS activity, but VLA-4 is not equally relevant for all immune cells; TH17 cells can enter the CNS without it, namely via MCAM expression. The MCAM phenotype will be analyzed, as well as its role in transmigration into the CNS, in immune surveillance under (non)inflammatory conditions, and its potential usage of integrin VLA-2, which is preferentially expressed by these cells. We will combine human and murine experiments using conventional approaches (kinase inhibitors, transgenic mice, EAE), but also state-of-the-art spinning-disc microscopy to visualize MCAM-mediated CNS infiltration in vivo.

KeywordsNeuroimmunologie; Multiple Sklerose
DFG-Gepris-IDhttps://gepris.dfg.de/gepris/projekt/223525770
Funding identifierTRR 128/2 | DFG project number: 213904703
Funder / funding scheme
  • DFG - Collaborative Research Centre (SFB)

Project management at the University of Münster

Schwab, Nicholas Christopher
Zarbock, Alexander

Applicants from the University of Münster

Schwab, Nicholas Christopher
Zarbock, Alexander

Projects of the following funding period

Duration: 01/01/2021 - 30/06/2024 | 3rd Funding period
Funded by: DFG - Collaborative Research Centre
Type of project: Subproject in DFG-joint project hosted at University of Münster

Related main project

Duration: 01/07/2016 - 31/12/2020 | 2nd Funding period
Funded by: DFG - Collaborative Research Centre
Type of project: Main DFG-project hosted at University of Münster